Cervical Cancer in the Era of HPV: Translating Molecular Mechanisms into Preventive Public Health Action
International Journal of Molecular Sciences · 30.08.2025 · 26 (17) · 8463
DOI: 10.3390/ijms26178463 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.08.2025. Verfasst von Lidia Boldeanu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy of Craiova, Romania.
Abstract (Originalsprache)
Cervical cancer remains a significant public health challenge, disproportionately affecting women in low- and middle-income countries (LMICs). Persistent infection with high-risk types of human papillomavirus (HPV), particularly HPV16 and HPV18, is the central cause of cervical carcinogenesis, driven by the viral oncoproteins E6 and E7, which disrupt the host tumor suppressors p53 and retinoblastoma protein (pRb). Advances in molecular understanding have catalyzed effective primary and secondary prevention strategies. Prophylactic HPV vaccination, especially the nonavalent formulation, has demonstrated high efficacy in reducing HPV infections and cervical precancer. Concurrently, HPV deoxyribonucleic acid (DNA) testing, self-sampling, and screen-and-treat protocols are transforming screening paradigms, particularly in resource-limited settings. However, global disparities in vaccine access, screening coverage, and health infrastructure persist, impeding progress toward the World Health Organization’s (WHO) 90–70–90 elimination targets. By synthesizing recent advances in virology, prevention strategies, and implementation innovations, such as therapeutic vaccines, artificial-intelligence (AI)-driven diagnostics, and mobile health solutions, this review sheds light on their potential to narrow these equity gaps.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Immunology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Obstetrics and Gynecology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
ORCID-Profile: Lidia Boldeanu, Mohamed-Zakaria Assani, Mihail Virgil Boldeanu, Constantin-Cristian Văduva
Förderung
- University of Medicine and Pharmacy of Craiova, Romania
Zitieren
APA
Boldeanu, L., Assani, M. Z., Boldeanu, M. V., Siloși, I., Manolea, M. M., Văduva, C. C., Assani, A. D., & Dijmărescu, A. L. (2025). Cervical Cancer in the Era of HPV: Translating Molecular Mechanisms into Preventive Public Health Action. International Journal of Molecular Sciences, 26(17), 8463. https://doi.org/10.3390/ijms26178463
Vancouver
Boldeanu L, Assani MZ, Boldeanu MV, Siloși I, Manolea MM, Văduva CC, et al. Cervical Cancer in the Era of HPV: Translating Molecular Mechanisms into Preventive Public Health Action. International Journal of Molecular Sciences. 2025;26(17):8463. doi:10.3390/ijms26178463
BibTeX
@article{Boldeanu2025,
author = {Boldeanu, Lidia and Assani, Mohamed-Zakaria and Boldeanu, Mihail Virgil and Siloși, Isabela and Manolea, Maria-Magdalena and Văduva, Constantin-Cristian and Assani, Alexandru-Dan and Dijmărescu, Anda Lorena},
title = {Cervical Cancer in the Era of HPV: Translating Molecular Mechanisms into Preventive Public Health Action},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {17},
pages = {8463},
doi = {10.3390/ijms26178463}
}
EUVIMED